December 1, 2021

An article published in Blood Advances reviewed past and ongoing clinical trials of adoptive immunotherapy for patients with classic Hodgkin lymphoma (cHL). The article also examined current challenges and strategies specific to improving the development of CAR T-cell therapy for cHL in general and relapsed or refractory cHL in particular.  The authors gathered data from eight past...